HCP preference: In-person / Concise efficacy updates

Last interactions: 2026-01-24 (needs-follow-up), 2026-01-14 (neutral)

Suggested agenda: recap prior commitment, approved update on product access, agree follow-up date.

Talking points (guardrailed): approved claims only, no treatment recommendation, route scientific questions to MI.

Follow-up checklist: send approved recap, log note tags, assign due date task.

Last note: Discussed current treatment pathway, reviewed approved resources, and aligned on follow-up materials.